C

롤링스톤

214610KOSDAQ

49.5 / 100

Reference Date: 2026-09-08

Financial Score22.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Rolling Stone Co., Ltd., established in 2009, specializes in developing molecular diagnostic equipment and kits based on LabChip technology, holding patents in 17 countries. The company offers solutions for infectious disease diagnosis, A2 milk detection, immuno/biochemical diagnostic products, and is expanding into digital healthcare and fuel trading to diversify its portfolio and achieve sustainable growth.

Number of Employees

16people

Average Salary

54.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
1.20Industry Average 1.204.0Point

In line with industry avg

ROE
-115.23Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
6.64Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲60.5% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲24.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -104.4% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 2,290Won52-week high 4,84052-week low 2,255
1-month return3.0Point

1m 0% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)2026-08-14